Is'Pangolin(Manis Squama)is not used in medicine'an improvement in the protection of precious and rare species or an improvement in the safety of using medicine?

摘要

Recently,a number of reports about pangolin have become hot news:The Chinese Pharmacopoeia(2020 edition)has not continued to include the drug-using standards for pangolin(Manis Squama),aristolochic(Aristolochia debilis Sieb.et Zucc),celestial vine(Fibraurea recisa Pierre),and Chinese patent drug Huanglian Yanggan pills(approval number by China State Food and Drug Administration:Z200113194).On June 5,2020,the China Forestry Administration Bureau and the Grassland Bureau co-issued an announcement to upgrade all the species of genus pangolins from the national second level of the protected wildlife to the first level.The new coronavirus(SARS-CoV-2)is also highly similar to the beta coronavirus isolated from pangolin[1].